OTC : ATSAF

ATS Corporation

$44.25 USD

$0 (0.0%)

Volume
435
Average Volume
44.46K
Market Capitalization
$4.06B
P/E Ratio
51.69
Dividend Yield
0.00%
Price Target
Year High
$45.80
Year Low
$25.66
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.64
Company Overview

OTC

Andrew P. Hider

Industrial - Machinery

Industrials

ATSAF

6000

CA

USD

https://www.atsautomation.com

519 653 6500

N/A

N/A

Liquidity Metrics

0.81

1.64

1.36

0.27

0.00

Sales & Valuation

$2.58B

1.25

2.11

9.46

4.00

Profitability

$1.38

$127.43M

2.41%

3.34%

4.08%

1.65%

P/E Metrics

51.69

0.02

0.02

Analyst Price Target & Rating

N/A

0/5

1 Analysts

%

Financial Health Scores

2.70

8/9

$408.4M

$3.54B

$2.41B

$222.49M

Key Metrics (TTM)

$4.86B

1.64

13.59

1.64

4.08%

4.74%

1.91%

10.57%

$17.26

66 days

Company Executives
Name Title
Angella Alexander Chief HR Officer
Chris Hart Pres of Life Sciences
Poll Results

No votes yet today — be the first to share your view!

About ATS Corporation (OTC:ATSAF) Stock

ATS Corporation furnishes advanced automation solutions to clients across the globe. The company oversees the complete lifecycle of automated manufacturing and assembly systems, spanning from initial conceptualization and engineering to construction, deployment, and ongoing maintenance, while also providing its own automation products and sophisticated testing capabilities. ATS offers extensive enterprise-level support, which includes project oversight, supplier coordination, facility planning, business case development, and critical post-project services such as spare parts, continuous support, system validation, and training. Its service portfolio further encompasses pre-automation activities like discovery, concept refinement, simulation, and total cost analysis, as well as post-automat ... ion assistance covering user training, process optimization, routine maintenance, emergency support, and equipment refurbishment or relocation. Additionally, ATS undertakes contract manufacturing and a broad array of engineering and technical services, including design, prototyping, software development, equipment integration, and comprehensive documentation. The corporation serves diverse sectors such as life sciences, transportation, consumer products, food and beverage, and energy. Established in 1978 and headquartered in Cambridge, Canada, the company rebranded to ATS Corporation in November 2022, having previously operated as ATS Automation Tooling Systems Inc.

Earnings Preview: ATS (ATS) Q1 Earnings Expected to Decline

2026-07-30 11:01:53

ATS (ATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ATS Announces Dates of First Quarter Results Conference Call and Annual Meeting of Shareholders

2026-07-23 19:00:00

CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) will report its financial results for the first quarter ended June 28, 2026, before markets open on Thursday August 06, 2026. At 8:30 a.m. Eastern on August 06, 2026, the Company will host a conference call and webcast of management's quarterly remarks and follow up question and answer period with analysts. The listen-only webcast can be accessed at https://events.q4inc.com/attendee/766230709 an.

OTC Markets and Elysium Connect OTC Link ATS to Digital Asset Custodians

2026-07-15 07:00:00

Elysium's MatchHub will bridge OTC Link ATS and digital asset custodians, closing the interoperability gap between market structures Elysium's MatchHub will bridge OTC Link ATS and digital asset custodians, closing the interoperability gap between market structures

Kayan Announces US-Regulated ATS Sets August 3, 2026 Listing Date

2026-07-06 23:25:00

Kayan Project, Veea Inc. and Panoptes PBC turn AI into humanity's force multiplier for the preservation of natural environments and sustainable communities Kayan Project, Veea Inc. and Panoptes PBC turn AI into humanity's force multiplier for the preservation of natural environments and sustainable communities

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS

2026-06-30 10:00:00

GREENWICH, Conn.--(BUSINESS WIRE)-- #IBKR--Interactive Brokers (Nasdaq: IBKR) announced the launch of select Korean equities through Nextrade.

Implied Volatility Surging for ATS Corporation Stock Options

2026-06-22 11:55:32

Investors need to pay close attention to ATS stock based on the movements in the options market lately.

Fusemachines Expands Access to Agentic AI for Talent Acquisition Through Broad ATS Connectivity

2026-06-18 08:30:00

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Fusemachines Inc. (NASDAQ: FUSE), a leading provider of enterprise AI products and services, today announced expanded enterprise access to its Agentic AI for Talent Acquisition platform through new connectivity with more than 30 enterprise applicant tracking systems (ATS), enabling Fusemachines Agents to work directly within the systems organizations already use to manage talent and hiring. This expanded connectivity represents the first in a broader series of planned platform enhancements designed to bring AI-powered recruiting capabilities closer to the workflows, data, and systems recruiters rely on every day.

New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF

2026-06-18 04:05:00

Not intended for UK and US audiences  Nerandomilast long-term survival modeling presented at American Thoracic Society (ATS) 2026 and European Alliance of Associations for Rheumatology (EULAR) 2026 international congresses. Based on the modeling, nerandomilast consistently increased median survival in both idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).1,2 Modeling predicts meaningful extensions in survival with nerandomilast, including a multi-year increase in median survival when used as monotherapy, and additional gains when added to standard treatment.1,2 Ingelheim, Germany - Long-term survival modeling of Boehringer Ingelheim's oral preferential PDE4B inhibitor, nerandomilast, predicts the therapy could extend survival by up to 5.4 years in adults with idiopathic pulmonary fibrosis (IPF) and up to 3.3 years in adults with progressive pulmonary fibrosis (PPF), compared with no therapy.1,2 These findings are based on data from the Phase III FIBRONEER™ trials and were recently presented at the ATS and EULAR 2026 international congresses.

Frequently Asked Questions

What is the current ATS Corporation (ATSAF) stock price?

ATS Corporation(OTC:ATSAF) stock price is $44.25 in the last trading session. During the trading session, ATSAF stock reached the peak price of $45.8 while $25.66 was the lowest point it dropped to. The percentage change in ATSAF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ATSAF stock was $0.

ATSAF's industry and sector of operation?

The OTC listed ATSAF is part of Industrial - Machinery industry that operates in the broader Industrials sector.

Who are the executives of ATSAF?

Angella Alexander | Chief HR Officer
Chris Hart | Pres of Life Sciences
|
|
|

How many employees does ATSAF have?

Number of ATSAF employees currently stands at 6000. ATSAF operates from 730 Fountain Street North, Cambridge, ON N3H 4R7, CA.

Link for ATSAF official website?

Official Website of ATSAF is: https://www.atsautomation.com

How do I contact ATSAF?

ATSAF could be contacted at phone #519 653 6500 and can also be accessed through its website. ATSAF operates from 730 Fountain Street North, Cambridge, ON N3H 4R7, CA.

How many shares of ATSAF are traded daily?

The average number of ATSAF shares traded daily for last 3 months was 44.46K.

What is the market cap of ATSAF currently?

The market value of ATSAF currently stands at $4.06B with its latest stock price at $44.25